# FDA Inspection 860212 - Ascension Health - December 26, 2013

Source: https://www.keypedia.com/records/fda_inspections/ascension-health/1263a65c-7a7d-45fb-841d-5dcd0b2b27c4
Source feed: FDA_Inspections

> FDA Inspection 860212 for Ascension Health on December 26, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 860212
- Company Name: Ascension Health
- Inspection Date: 2013-12-26
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1276328 - 2025-07-10](https://www.keypedia.com/records/fda_inspections/ascension-health/8acd8d9e-81ff-44d1-9c43-8d55322fbd2d)
- [FDA Inspection 1276328 - 2025-07-10](https://www.keypedia.com/records/fda_inspections/ascension-health/c94e68e9-9277-4568-8367-61337509253c)
- [FDA Inspection 1191022 - 2022-10-13](https://www.keypedia.com/records/fda_inspections/ascension-health/eca8ebcd-8f8e-4efe-b2e6-d14202bb1cd1)
- [FDA Inspection 1191022 - 2022-10-13](https://www.keypedia.com/records/fda_inspections/ascension-health/a415d933-85ae-42f3-9228-b74751feaa85)
- [FDA Inspection 1037436 - 2017-11-29](https://www.keypedia.com/records/fda_inspections/ascension-health/f0d9dc85-c1d5-479a-b422-42236b106b9b)

Company: https://www.keypedia.com/companies/ascension-health/aa996453-4934-4564-81a0-cff1afc9f1dc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d